Traditional Chinese medicine composition for treating polycythemia vera

Abstract

The invention discloses a traditional Chinese medicine composition for treating polycythemia vera. The traditional Chinese medicine composition comprises the following raw materials: felwort, chrysanthemum, scutellaria baicalensis in wine, cape jasmine, semen plantaginis, starwort root, rhizoma alismatis, rhizoma sparganii, aloes, indigo naturalis, oldenlandia diffusa, safflower carthamus, caulis spatholobi, codonopsis pilosula, agastache rugosus and cortex moutan. The traditional Chinese medicine composition adopts a principle of treatment based on syndrome differentiation, has the effects of activating blood to remove stasis, clearing the liver to discharge heat, nourishing the kidney yin and reducing the liver yang in combination with difference of extravasated blood from blood heat, and is prepared by mixing the raw materials through multi-time clinical verifications; after the traditional Chinese medicine composition is taken, the traditional Chinese medicine composition enters a human body, the effect is quickly brought into play, the stasis and heat can be removed, the concentration of red blood cells is effectively reduced, the blood viscosity and the blood resistance are reduced, and finally the effects of unblocking channels and regulating yin and yang are achieved, so that the clinical symptoms and various laboratory indicators of patients return to normal and the purpose of clinical treatment is achieved.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating polycythemia vera. Background technique [0002] Polycythemia vera, referred to as "true red", is an acquired clonal hematopoietic stem cell disease, characterized by an absolute increase in the number of red blood cells and whole blood volume, increased blood viscosity, and often accompanied by an increase in white blood cells and platelets. The clinical manifestations are purplish skin and mucous membranes, splenomegaly, high blood pressure, and prone to thrombosis, embolism and bleeding. [0003] According to epidemiological statistics, the incidence of polycythemia vera in the population is about 0.6 / 100,000 to 1.6 / 100,000, and it is more common in middle-aged and elderly men. The number of red blood cells in the peripheral blood of patients is significantly increased, and the blood viscosity is about normal....

AI Technical Summary

Problems solved by technology

[0004] Western medicine mostly uses methods such as Maryland, cyclophosphamide, hydroxyurea and venous bloodletting to treat polycythemia vera. Although it can alleviate the condition, it cannot fundamentally solve the problem. It only improves the clinical symptoms and maintains the life of the patient, and the toxicity of the drug Reaction and repeated massive bloodletting make the patient worry